Harbor Capital Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Buy
26,628
+4,872
+22% +$175K 0.06% 393
2026
Q1
$769K Buy
21,756
+1,603
+8% +$65.2K 0.06% 376
2025
Q4
$818K Buy
20,153
+2,024
+11% +$88K 0.06% 371
2025
Q3
$853K Buy
18,129
+2,344
+15% +$122K 0.07% 357
2025
Q2
$822K Sell
15,785
-5,558
-26% -$305K 0.03% 462
2025
Q1
$1.29M Buy
+21,343
New +$1.38M 0.06% 376

Other funds holding CNMD

Harbor Capital Advisors's CNMD Position: Q2 2026 in Review

Harbor Capital Advisors increased its CONMED (CNMD) stake by 22% in Q2 2026, buying an estimated $175K and bringing the position to 26,628 shares worth $872K. The position accounts for 0.06% of the portfolio, ranked #393.

Harbor Capital Advisors first reported a position in CNMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.29M in Q1 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Harbor Capital Advisors held 26,628 shares of CONMED worth $872K as of Q2 2026.
  • Harbor Capital Advisors bought 4,872 CONMED shares in Q2 2026, an estimated $175K.
  • CONMED made up 0.06% of Harbor Capital Advisors's portfolio in Q2 2026, its #393 holding.
  • Harbor Capital Advisors first reported a position in CONMED in Q1 2025 and has held it in 6 quarters since.
  • Harbor Capital Advisors's CONMED position peaked at $1.29M in Q1 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.